A recent study has found that while Transurethral Microwave Thermotherapy (TUMT)—utilizing the Prostatron device and Prostasoft v2.5 software—yields significant improvements in the symptoms of benign prostatic hyperplasia (BPH), it does not sufficiently reduce urinary obstruction caused by the condition.
BPH is a common condition in aging men, characterized by the non-cancerous enlargement of the prostate gland, which can lead to troublesome lower urinary tract symptoms such as increased urinary frequency, urgency, and weakened stream. TUMT is a minimally invasive procedure used as an alternative to surgical intervention for BPH, involving the use of microwave energy to reduce excess prostate tissue.
The study’s findings suggest that although the TUMT procedure provides substantial relief in terms of symptom management, it does not address the physical blockage or obstruction in the urinary tract effectively. This distinction is important for treatment planning, especially for patients looking for a long-term solution to urinary flow issues.
Furthermore, patients undergoing TUMT therapy with the use of this specific software should be counseled about potential side effects. One noted adverse effect is ejaculatory dysfunction, a condition that can impact quality of life and sexual well-being. Clinicians are advised to discuss both the benefits and limitations of TUMT with patients, particularly with respect to expectations regarding symptom relief versus mechanical improvement in urinary function.
These findings underline the need for a comprehensive, individualized approach in managing BPH, with careful consideration given to both efficacy and side effects of treatment options.
Source: https:// – Courtesy of the original publisher.
